Arrowhead Research | ARWR - Pasivo Circulante

Precio De Mercado
69.38
Cambio Diario
-1.15 -1.63%
Mensual
10.65%
Anual
394.16%
Q2 Expectativa
72.33




Pasivo Circulante Cambio Fecha
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Anika Therapeutics USD 20.97M 942K 2026-03
Arrowhead Research USD 347.42M 151.94M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Incyte USD 1.49B 25.52M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Merck USD 28.63B 2.59B 2025-09
Moderna USD 1.99B 306M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xencor USD 95.91M 9.42M 2025-12